Schedule 13D ownership disclosure

CYTOCORE INC

Security class unavailable · CUSIP: 23282B403

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
38.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-14-022808
Form type
SC 13D
Filer
Medite Cancer Diagnostics, Inc.
CIK
CIK 75439
Filed
Apr 15, 2014
Reporting period
—
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub